Cover Image
市場調查報告書

腦及組織的氧檢測設備的全球市場:2016∼2020年

Global Cerebral and Tissue Oximetry Devices Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 362087
出版日期 內容資訊 英文 50 Pages
訂單完成後即時交付
價格
Back to Top
腦及組織的氧檢測設備的全球市場:2016∼2020年 Global Cerebral and Tissue Oximetry Devices Market 2016-2020
出版日期: 2016年06月29日 內容資訊: 英文 50 Pages
簡介

腦及組織的氧檢測設備,是非侵入性的,持續測量腦組織的氧等級的設備。按照探針收送的光量差異,計算腦內的氧等級。全球腦及組織的氧檢測設備市場,預計2016∼2020年,以年複合成長率6.92%擴大。

本報告提供全球腦及組織的氧檢測設備市場現狀與到2020年的預測,市場規模與銷售趨勢,彙整主要供應商的競爭環境與簡介。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

第5章 腦及組織的氧檢測設備:已經過核准產品分析

第6章 成本和效益分析

第6章 全球醫療用電極市場

  • 市場規模與預測

第7章 市場情況

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第8章 各地區市場區隔

  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第9章 推動市場的要素

  • 腦低氧的發病率
  • 近紅外線光譜法的引進
  • 腦內出血

第10章 促進要素的影響

第11章 市場課題

  • 可取得的腦血氧計的限制
  • 嚴格的相關法規
  • 不利的償付方案

第12章 促進要素與課題的影響

第13章 市場趨勢

  • 多參數血氧計的開發
  • 產品認證
  • 銷售契約

第14章 供應商環境

  • 競爭模式
  • 主要供應商
  • 其他值得注意的供應商

第15章 附錄

第16章 關於Technavio

目錄
Product Code: IRTNTR8872

About the Cerebral and Tissue Oximetry Devices Market

Cerebral and tissue oximeters help physicians obtain non-invasive, continuous measures of cerebral oxygenation levels in the cerebral tissues. These near-infrared spectroscopy technology-based devices consist of an oximeter probe connected to a cerebral oximeter monitor via a cable. The oximeter probe is placed on the forehead, at an area with the least amount of hair. The oximeter also consists of a light detector and a fiber-optic light source. The device calculates the oxygen levels in the brain based on the difference between the amount of light sent and received by the probe. The values obtained are displayed on the screen of the monitor and calculated as percentage.

Technavio's analysts forecast the global cerebral and tissue oximetry devices market to grow at a CAGR of 6.92% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global cerebral and tissue oximetry devices market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of cerebral and tissue oximeters, including sensors, monitors, and software.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Cerebral and Tissue Oximetry Devices Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • CAS Medical Systems Inc.
  • Masimo Corp.
  • Medtronic plc
  • Nonin Medical Inc.

Other Prominent Vendors

  • Hamamatsu Photonics
  • Hutchinson Technology
  • HyperMed
  • ISS
  • Moor Instruments
  • Ornim Medical
  • Reflectance Medical
  • Spectros
  • ViOptix

Market driver

  • Incidence of cerebral hypoxia
  • For a full, detailed list, view our report

Market challenge

  • Limitations of available cerebral oximeters
  • For a full, detailed list, view our report

Market trend

  • Development of multi-parameter medical devices
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Cerebral and tissue oximeters: Analysis of approved products

  • Description about some key devices

PART 06: Cost and benefit analysis of cerebral and tissue oximeters

  • Cost and benefit analysis of INVOUS tissue oximeter

PART 07: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 08: Geographical segmentation

  • Cerebral and tissue oximetry devices market in Americas
  • Cerebral and tissue oximetry devices market in EMEA
  • Cerebral and tissue oximetry devices market in APAC

PART 09: Market drivers

  • Incidence of cerebral hypoxia
  • Incorporation of near-infrared spectroscopy
  • Monitoring intraventricular hemorrhage

PART 10: Impact of drivers

PART 11: Market challenges

  • Limitations of available cerebral oximeters
  • Stringent regulatory framework
  • Unfavorable reimbursement scenario

PART 12: Impact of drivers and challenges

PART 13: Market trends

  • Development of multi-parameter oximeters
  • Product approvals
  • Distribution agreements

PART 14: Vendor landscape

  • Competitive scenario
  • Key vendors
  • Other prominent vendors

PART 15: Appendix

  • List of abbreviations

PART 16: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Key 510(k) FDA-approved cerebral and tissue oximeters
  • Exhibit 03: Cost savings for cardiac surgeries that involved INVOUS tissue oximeter
  • Exhibit 04: Global cerebral and tissue oximetry devices market 2015-2020 ($ millions)
  • Exhibit 05: Five forces analysis
  • Exhibit 06: Global cerebral and tissue oximetry devices market segmentation by geography 2015
  • Exhibit 07: Global cerebral and tissue oximetry devices market segmentation by geography 2020
  • Exhibit 08: Global cerebral and tissue oximetry devices market segmentation by geography 2015-2020
  • Exhibit 09: Global cerebral and tissue oximetry devices market segmentation by geography 2015-2020 ($ millions)
  • Exhibit 10: Cerebral and tissue oximetry devices market in Americas 2015-2020 ($ millions)
  • Exhibit 11: Cerebral and tissue oximetry devices market in EMEA 2015-2020 ($ millions)
  • Exhibit 12: Cerebral and tissue oximetry devices market in APAC 2015-2020 ($ millions)
  • Exhibit 13: Impact of drivers
  • Exhibit 14: Impact of drivers and challenges
  • Exhibit 15: CAS Medical Systems: Business segmentation by revenue 2014
  • Exhibit 16: CAS Medical Systems: Business segmentation by revenue 2013 and 2014 ($ millions)
  • Exhibit 17: CAS Medical Systems: Revenue of tissue oximetry monitoring segment 2014
  • Exhibit 18: CAS Medical Systems: Revenue of tissue oximetry monitoring segment by region 2014
  • Exhibit 19: CAS Medical Systems: Geographical segmentation by revenue 2014
  • Exhibit 20: CAS Medical Systems: Key takeaways
  • Exhibit 21: Masimo: Business segmentation by revenue 2016
  • Exhibit 22: Masimo: Business segmentation by revenue 2015 and 2016 ($ millions)
  • Exhibit 23: Masimo: Key takeaways
  • Exhibit 24: Medtronic: Product offerings
  • Exhibit 25: Medtronic: Key takeaways
  • Exhibit 26: Nonin Medical: Key takeaways
  • Exhibit 27: Other prominent vendors
Back to Top